Research location
Laredo
Texas, United States
Advertisement
Research activity in Laredo
Texas, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 79 trials and 80 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Laredo
79 linked trials · page 2 of 2A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaNCT01578707 · 2012-06-01 · 1 site observation
COMPLETED
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerNCT01097278 · 2011-11-01 · 1 site observation
COMPLETED
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32NCT01286233 · 2011-07-01 · 1 site observation
UNKNOWN
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerNCT01242800 · 2011-05-16 · 1 site observation
COMPLETED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08 · 1 site observation
COMPLETED
Vitamin D and Breast Cancer Biomarkers in Female PatientsNCT01224678 · 2010-10-01 · 1 site observation
COMPLETED
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerNCT01101438 · 2010-08-13 · 1 site observation
COMPLETED
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerNCT00856492 · 2010-04-01 · 1 site observation
COMPLETED
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryNCT00861705 · 2009-07-21 · 1 site observation
COMPLETED
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00881361 · 2009-07-01 · 1 site observation
COMPLETED
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryNCT00770809 · 2009-02-24 · 1 site observation
COMPLETED
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10 · 1 site observation
COMPLETED
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerNCT00601900 · 2008-09-24 · 1 site observation
COMPLETED
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by SurgeryNCT00513292 · 2007-07-01 · 1 site observation
COMPLETED
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryNCT00408408 · 2006-11-01 · 1 site observation
UNKNOWN
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionNCT00376597 · 2006-06-01 · 1 site observation
COMPLETED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerNCT00265759 · 2006-01-01 · 1 site observation
COMPLETED
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast CancerNCT00093002 · 2004-06-01 · 1 site observation
COMPLETED
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066690 · 2003-12-17 · 1 site observation
COMPLETED
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03 · 1 site observation
COMPLETED
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyNCT00053898 · 2003-01-01 · 1 site observation
COMPLETED
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast CancerNCT00074152 · 2002-07-01 · 1 site observation
COMPLETED
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South TexasNCT00846300 · 2001-08-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituNCT00003857 · 1999-12-01 · 1 site observation
COMPLETED
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenNCT00003906 · 1999-05-01 · 1 site observation
COMPLETED
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerNCT00003855 · 1999-04-01 · 1 site observation
COMPLETED
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)NCT00054795 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.